Selected Publications

Colin J. Thomas, David Porter, Vivianna M. Van Deerlin, Siddharth Bhattacharyya, Veronica Carvajal, Joseph Kim, Salvatore Priore, Guang Yang, James N. Gerson & Stefan K. Barta: Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia Leukemia & Lymphoma February 2025.

Pallawi Torka, Natalie S. Grover, Timothy J. Voorhees, Reem Karmali, Kaitlin Annunzio, Marcus P. Watkins, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla: Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. Hematological Oncology April 2025.

Omar Elghawy, Jonathan H Sussman, Austin G Yang, Colin J Thomas, Jordan S Carter, Daniel J Landsburg, Jakub Svoboda, Ellen Kim, Alain H Rook, Jina Chung, John P Plastaras, Michael LaRiviere, Harper Hubbeling, Monica Chelius, Sunita D Nasta, Elise A Chong, Stephen J Schuster, Stefan K Barta: Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. JAMA Dermatology April 2025.

Omar Elghawy, Miao Cao, Jason Xu, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Colin J. Thomas, Jordan S. Carter, Montreh Tavakkoli, Marco Ruella and Stefan K. Barta: Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas. Cancers 16(19), October 2024.

Omar Elghawy, Julia Wang, Olivia J. Leung, Nishwant Swami, Veronica Carvajal, Guang Yang, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta1, Elise A. Chong1, Stephen J. Schuster1, Colin J. Thomas, Jordan S. Carter, Adam Bagg, Stefan K. Barta: Clinical Impact of Next-Generation Sequencing of T-cell Lymphomas: A Single Institution Experience. Clinical Lymphoma, Myeloma and Leukemia February 2025.

Omar Elghawy, Austin G. Yang, Jonathan H. Sussman, Colin J. Thomas, Jordan S. Carter, Daniel J. Landsburg, Jakub Svoboda, Ellen Kim, Alain H. Rook, Jina Chung, Jennifer Villasenor-Park, John P. Plastaras, Michael LaRiviere, Harper Hubbeling, Monica Chelius, Sunita D. Nasta, Elise A. Chong, Stephen J. Schuster, Stefan K. Barta: Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome. JAAD November 2024.

Epperla N, Welkie RL, Torka P, Shouse G, Karmali R, Shea L, Anampa-Guzmán A, Oh TS, Reaves H, Tavakkoli M, Lindsey K, Greenwell IB, Hansinger E, Thomas C, Chowdhury SM, Annunzio K, Christian B, Barta SK, Geethakumari PR, Bartlett NL, Herrera AF, Grover NS, Olszewski AJ.: Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study. J Hematol Oncol 16: 49, May 2023.

Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N.: Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study. Blood Cancer J 14: 182, Oct 2024.

Colin Thomas, Veronica Carvajal and Stefan Barta: Targeted Therapies in the Treatment of Mantle Cell Lymphoma. Cancers. MDPI, 16(10): 1937, May 2024 Notes: https://doi.org/10.3390/cancers16101937.

Epperla N, Zhao Q, Moyo T, Watkins MP, Tavakkoli M, Bello C, Torka P, Reddy N, Thomas C, Annunzio K, Christian B, Barta SK, Shouse G, Olszewski AJ, Bartlett NL.: Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in USA: A Real World Analysis. Blood Adv Dec 2023.

Rosenberg M, Poluch M, Thomas C, Sindaco P, Khoo A, Porcu P.: Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities. Front Oncol 13: 1275800, Oct 2023.

Epperla, N., Zhao, Q., Chowdhury, S., Shea, L., Moyo, T., Reddy, N., Sheets, J., Weiner, D., Geethakumari, P., Kandarpa, M., Bruno, X., Thomas, C., Churnetski, M., Hsu, A., Zurbriggen, L., Tan, C., Lindsay, K., Maakaron, J., Caimi, P., Torka, P., Bello, C., Ayyappan, S., Karmali, R., Kim, S., Kress, A., Kothari, S., Sawalha, Y., Christian, B., David, K., Greenwell, I., Janakiram, M., Kenkre, V., Olszewski, A., Cohen, J., Palmisiano, N., Umyarova, E., Wilcox, R., Awan, F., Alderuccio, J., Barta, S., Grover, N., Ghosh, N., Bartlett, N., Herrera, A., Shouse, G.: Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study. J Hematol Oncol 15(1): 96, Jul 2022.

Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh TS, Anampa-Guzmán A, Reves H, Tavakkoli M, Greenwell IB, Hansinger E, Umyarova E, Annunzio K, Sawalha Y, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Grover NS, Olszewski AJ.: Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study. Blood Adv 7: 5038-5046, Sep 2023.

Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan XC, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G.: Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood Adv 7: 88-91, Jan 2023.

Colin Thomas, Sameep Thapa, Connor McLaughlin, Molly Halloran, Pierluigi Porcu. : Point and counterpoint: polatuzumab vedotin in the front-line therapy for diffuse large b-cell lymphoma. Front Oncol 12: 1098375. Jan 2023.

Colin Thomas, Christine Kurian, Sarah Houtmann, Neil Palmisiano. : Efficacy of half-day workshops for internal medicine interns in educating breaking-bad-news conversations. Palliat Med Rep 2(1): 132-136, May 2021.

Christine J Kurian, Colin Thomas, Sarah Houtmann, Thomas Klumpp, Adam Finn Binder.: Case report: concomitant diagnosis of plasma cell leukemia in patient with JAK2 positive myeloproliferative neoplasm. Front Oncol 27: 10:1497. Aug 2020.

Thomas, C., Ji, Y., Wu, C., Datz, H., Boyle, C., MacLeod, B., Patel, S., Ampofo, M., Currie, M., Harbin, J., Pechenkina, K., Lodhi, N., Johnson, S, Tulin, A.: Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processes. Proc Natl Acad Sci U S A 116(20): 9941-9946, May 2019.

Colin Thomas, Yingbiao Ji, Niraj Lodhi, Elena Kotova, Aaron Dan Pinnola, Konstantin Golovine, Peter Makhov, Kate Pechenkina, Vladimir Kolenko, Alexei V Tulin. : Non-NAD-like poly(ADP-ribose) polymerase-I inhibitors effectively eliminate cancer in vivo. EBioMedicine 13: 90-98, Nov 2016.

Yingbiao Ji, Colin Thomas, Nikita Tulin, Niraj Lodhi, Ernest Boamah, Vladimir Kolenko, Alexei V Tulin. : Charon mediates immune deficiency- driven PARP-I-dependent immune responses in drosophila. J Immunol 197(6): 2382-9, Sep 2016.

Colin Thomas, Sujana Movva : Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival. Onco Targets Ther 9: 9:5619-27, Sep 2016.

Colin Thomas, Alexei V Tulin : Poly-ADP-ribose polymerase: machinery for nuclear processes Mol Aspects Med 34(6): 1124-37, Dec 2013.

Colin J Thomas, Elena Kotova, Mark Andrake, Jared Adolf-Bryfogle, Robert Glaser, Catherine Regnard, Alexei V Tulin.: Kinase-mediated changes in nucleosome conformation trigger chromatin decondensation via poly- ADP-ribosylation. Mol Cell 53(5): 831-42, Mar 2014.

Colin Thomas, Elena Kotova, Alexei V Tulin : PARP-I interaction with and activation by histones and nucleosomes. Methods Mol Biol 1608: 255-267, 2017 Notes: 10.1007/978-1-4939-6993-7_17